Project Grant R01MH137102
- Federal Project Grant Award Summary Baylor College of Medicine received a $778,543 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective August 1, 2025, through July 31, 2030. This award supports a five-year neurophysiological investigation examining the approach-avoidance behavioral axis in obsessive-compulsive disorder (OCD) and its applications to neuromodulation therapy. The research focuses on understanding...
- Federal Grant Award Summary Baylor College of Medicine received a $246,562 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 13, 2025, with completion targeted for October 12, 2027. The award supports investigator-initiated research examining causal inference in bimanual tactile processing—specifically, how the brain determines...
- Federal Grant Award Summary Under the Mental Health Research Grants program (CFDA 93.242) administered by the National Institute of Mental Health, the University of California, Los Angeles received a $424,433 Project Grant award effective March 1, 2026, with a completion date of December 31, 2029. This award supports the development of practical frameworks and implementation tools to improve participant engagement in brain-computer interface (BCI) early feasibility studies. The project will...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded $409,750 to the University of Alabama at Birmingham under the Mental Health Research Grants program (CFDA 93.242) on March 15, 2026, for a two-year research project concluding March 14, 2028. This project grant funds fundamental neuroscience research investigating the role of localized dopamine signals in learning and neural circuit function. The research employs two-photon microscopy and genetically...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Feinstein Institutes for Medical Research a Project Grant of $519,558 under the Mental Health Research Grants program (CFDA 93.242), effective June 15, 2025 through April 30, 2030. The research project focuses on identifying and validating cerebellar-cortical circuitry biomarkers as predictive indicators of antipsychotic treatment response in first-episode psychosis patients. The primary deliverables...
- Federal Grant Award Summary The Medical College of Wisconsin, Inc. received a $521,266 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, with a completion date of January 31, 2031. This award supports basic neuroscience research investigating the role of mechanistic target of rapamycin (mTOR) signaling in midbrain dopamine neurons and its relationship to hyperactivity and impulsivity...
- Federal Grant Award Summary Baylor College of Medicine received a $624,825 Project Grant award from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective March 15, 2026, with a completion date of February 28, 2031. The award supports research focused on developing computational methods to characterize the electrophysiological and genomic profiles of gliomas,...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a $1.45M Project Grant under the Mental Health Research Grants program (CFDA 93.242) on April 15, 2025, to develop an engineered bioprinting platform for studying neural migration in brain assembloids. The project, scheduled for completion by February 28, 2030, will deliver a novel magnetic three-dimensional bioprinting technology termed SPOT to enhance the quality,...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant of $443,931 under the Mental Health Research Grants program (CFDA 93.242) for the period July 1, 2025 through June 30, 2027. This research project aims to develop and validate novel methodologies for accurately tracking structural brain changes using low-field (0.05T) magnetic resonance imaging (MRI) technology coupled with autonomous control systems and...
- Federal Project Grant Award Summary The University of California, San Diego received a $415,664 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on March 15, 2026, with a completion date of December 31, 2030. This award supports a research project investigating the dissociable roles of distinct orbitostriatal circuits in value-based decision-making. The research employs advanced neuroscientific...
Baylor College of Medicine received a $445,816 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded March 5, 2026, with a completion date of December 31, 2029. The project, titled "Ethics and Decision-Making in Translational Neurological Device Research," addresses critical ethical gaps in early translational first-in-human (FIH) neuro device research. The primary deliverables include empirical investigation and analysis of ethical decision-making processes among both clinician-researchers and patient-subjects participating in or considering enrollment in FIH translational neurological device studies supported by NIH funding. The research will examine vulnerabilities, decisional challenges, and informational needs specific to patients with refractory medical conditions considering participation in translational neuro device research. Key products of the award include evidence-based findings on patient-centered perspectives regarding participation in FIH neuro device trials, identification of decisional biases (such as optimism bias and translational misconception), and development of tools and approaches to improve informed consent and decision-making processes. The project balances ethical protections for vulnerable patient populations against unjustified paternalism, generating actionable recommendations to support ethically sound participation decisions in early-stage translational neurological device research.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $445.8k | 3/5/26 |